These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7998096)

  • 1. RS-61443: a new immunosuppressive agent.
    Young CJ; Sollinger HW
    Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
    Deierhoi MH; Sollinger HW; Diethelm AG; Belzer FO; Kauffman RS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):693-4. PubMed ID: 8438440
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
    Takahashi K; Ochiai T; Uchida K; Yasumura T; Ishibashi M; Suzuki S; Otsubo O; Isono K; Takagi H; Oka T
    Transplant Proc; 1995 Feb; 27(1):1421-4. PubMed ID: 7878933
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new immunosuppressor: CellCept].
    Mouly-Bandini A
    Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816
    [No Abstract]   [Full Text] [Related]  

  • 5. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.
    Allison AC; Eugui EM
    Transplant Proc; 1994 Dec; 26(6):3205-10. PubMed ID: 7998117
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression strategies in kidney transplantation.
    Yango A; Johnsingh A
    Med Health R I; 2007 Mar; 90(3):80-3. PubMed ID: 17601287
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy.
    Salaman JR; Griffin PJ; Johnson RW; Kohlhaw K; Land W; Moore R; Pichlmayr R; Sells R
    Transplant Proc; 1993 Feb; 25(1 Pt 1):695-6. PubMed ID: 8438441
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent.
    Platz KP; Eckhoff DE; Hullett DA; Sollinger HW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):497-8. PubMed ID: 1990598
    [No Abstract]   [Full Text] [Related]  

  • 9. RS-61443 reverses acute renal allograft rejection in dogs.
    Platz KP; Bechstein WO; Eckhoff DE; Hullett DA; Sollinger HW
    Transpl Int; 1992; 5 Suppl 1():S542-3. PubMed ID: 14621871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RS-61443--a new, potent immunosuppressive agent.
    Platz KP; Sollinger HW; Hullett DA; Eckhoff DE; Eugui EM; Allison AC
    Transplantation; 1991 Jan; 51(1):27-31. PubMed ID: 1987698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of RS61443 on chronic rejection of rat kidney allografts.
    Azuma H; Binder J; Heemann U; Tullius SG; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):436-7. PubMed ID: 7879052
    [No Abstract]   [Full Text] [Related]  

  • 12. RS-61443 for treatment-resistant human liver rejection.
    Klintmalm GB; Ascher NL; Busuttil RW; Deierhoi M; Gonwa TA; Kauffman R; McDiarmid S; Poplawski S; Sollinger H; Roberts J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):697. PubMed ID: 8438442
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living unrelated kidney donation: an underutilized resource?
    Ploeg RJ; Pirsch JD; Stegall MD; Armbrust MJ; Lorentzen DF; D'Alessandro AM; Knechtle SJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1532-4. PubMed ID: 8442177
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate-update after it has come of age.
    Grinyó JM
    Nephrol Dial Transplant; 1999 Jan; 14(1):31-4. PubMed ID: 10052471
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of immunoglobulin resynthesis after plasmapheresis: efficacy of various immunosuppressive drugs--a study in rats.
    Kozlowski T; Tibell A; Morpurgo E; Sundberg B; Sundin U; Groth C
    Transplant Proc; 1995 Dec; 27(6):3545-6. PubMed ID: 8540094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of RS-61443 on antibody-mediated rejection.
    Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW
    Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil (RS 61443): nothing new under the sun or an important break-through in the field of transplantation?
    van der Woude FJ
    Nephrol Dial Transplant; 1995; 10(7):1112-5. PubMed ID: 7478104
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443.
    Gunji Y; Ochiai T; Sakamoto K; Suzuki T; Nagata M; Nakajima K; Komori A; Asano T; Isono K; Hamaguchi K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):752-3. PubMed ID: 7679841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.